Njengoko sijongene nomceli mngeni wonyango lomhlaza we-colorectal one-HER2-positive, siyaqonda ngokupheleleyo umnqweno wakho ongxamisekileyo wokhetho lonyango olusebenzayo noluphucukileyo. Namhlanje, sizisa iindaba ezikhuthazayo ezivela kwicandelo le-oncology laseTshayina.
**Unyango Oluphumelelayo Lufikeleleka: I-SHR-A1811 Ibonisa Amandla Angaqhelekanga**
Ngomhla wama-28 kuJanuwari ngo-2025, iZiko loVavanyo lwaMayeza (i-CDE) le-National Medical Products Administration yaseTshayina libhengeze ukuba i-SHR-A1811, i-antibody-drug conjugate entsha (ADC) eyenziwe ngokuzimeleyo yi-Hengrui Pharma, icetywayo ukuba ijongwe kuqala. Yenzelwe unyango lwezigulane ezindala ezinomhlaza we-colorectal one-HER2-positive eziye zasilela kunyango lwangaphambili nge-oxaliplatin, i-fluorouracil, kunye ne-irinotecan. Oku kubonisa inyathelo elibalulekileyo ekusetyenzisweni kwayo kwezonyango kumhlaza we-colorectal, okunika ithemba elitsha kwizigulane eziye zasebenzisa iindlela zonyango eziqhelekileyo.
Ekubeni sele ibonakalise ukusebenza kakuhle, eli yeza lavunywa eTshayina ngoMeyi 2025 kumhlaza wemiphunga ongengowe-HER2-mutant, laba liyeza lokuqala laseTshayina eliphuhlisiweyo ngokuzimeleyo le-ADC elivunyiweyo kuloo ntsimi. Ngoku, idatha yalo yezonyango kumhlaza we-colorectal ithembisa ngokufanayo: ngokweziphumo zovavanyo lweklinikhi lweSigaba 1 ezivezwe kwi-European Society for Medical Oncology (ESMO) Congress, kwidosi ecetyiswayo, izinga lokuphendula elijolise ngqo (ORR) lifikelele kwi-46.9%, kwaye izinga lokusinda elingenayo inkqubela phambili yeenyanga ezi-6 laliphezulu njenge-85.5% kwizigulana ezine-HER2-positive colorectal cancer. Ezi datha zibonisa amandla abalulekileyo okuphucula ukusinda kwizigulana ezine-HER2-positive colorectal cancer.
**Kutheni Ukhetha iSebe leMicimbi yeHlabathi leSibhedlele se-Oncology saseBeijing South Region?**
Ngokuchasene nobuchwepheshe bezonyango obuphucuka ngokukhawuleza eTshayina, indlela yokufumana olu nyango luphambili ngokukhuselekileyo, ngokukhawuleza, nangokufanelekileyo yeyona nto iphambili kwizigulane zamazwe ngamazwe. ISebe leeNgcali zeSibhedlele saseBeijing South Region Oncology International lasekwa ngenxa yale njongo:
1. **Indlela Ekhawulezileyo Yonyango Oluphambili:** Sijonga ngokusondeleyo ukuvunywa kwamayeza akutshanje kunye nophuhliso lophando lwezonyango eTshayina. Singavavanya kwaye sinike izigulane zamazwe ngamazwe ezifanelekileyo ukufikelela kwiindlela zonyango oluphambili.
2. **Iinkonzo eziBanzi ezisemgangathweni weHlabathi:** Ukususela kwiingcebiso zonyango zobungcali kunye nokuguqulelwa kweelwimi ezimbini (isiTshayina-isiNgesi) kunye novavanyo lweerekhodi zonyango ukuya ekucwangcisweni kweleta yesimemo se-visa echanekileyo, kulandele ukuhanjiswa "kwento enye" ngexesha lokulaliswa esibhedlele, uncedo lobomi bemihla ngemihla, kunye nokulandelela emva kokukhululwa esibhedlele, sinikezela ngeenkonzo ezibanzi, ezenzelwe wena ukuqinisekisa uhambo lwezonyango oluhamba kakuhle nolungenaxhala eTshayina.
3. **Iqela lezonyango eliPhezulu kunye neNdalo:** Esi sibhedlele sidibanisa iingcali ezidumileyo ze-oncology ezivela kulo lonke elaseTshayina, zixhotyiswe ngetekhnoloji yokuxilonga kunye neyonyango ephucukileyo. Sikwabonelela ngeewadi zezigulana zamazwe ngamazwe ezikhululekileyo kunye nendawo yonyango egxile kwisigulana, siqinisekisa ukuba unyango lunikezelwa ngobungcali besayensi kunye novelwano.
**Nxibelelana Nathi Ngoku Ukuze Uqalise Uhambo Lwakho Lwethemba**
Siyaqonda ukubaluleka kwexesha kunyango lomhlaza. Ukuba wena okanye umntu omthandayo ujongene nomhlaza we-colorectal one-HER2-positive okanye eminye imingeni ye-oncological kwaye unqwenela ukufunda okungakumbi malunga ne-SHR-A1811 okanye ezinye iindlela zonyango zamva nje, nceda ungathandabuzi ukuqhagamshelana nathi ngoko nangoko nangayiphi na kwezi ndlela zilandelayo:
- Inombolo yoNcedo lweNkonzo: 400-880-3716
**Ezinye Iindlela Zokunxibelelana Ezilula:**
- **WeChat:** Nceda wongeze i-ID `17801183037`. Abaququzeleli bethu bezonyango baza kubonelela ngoncedo lonxibelelwano olukwi-intanethi ngoko nangoko.
- **I-imeyile:**
- 100085_010@163.com
- myimmnet@163.com
Ungathumela isishwankathelo sakho sezonyango kunye neengxelo zovavanyo ezifanelekileyo kwiidilesi ze-imeyile ezingentla, kwaye siya kulungiselela uvavanyo lokuqala lweengcali.
Yonke inkqubela phambili kwezobuchwepheshe inika ithemba elitsha kubomi obungenakubalwa. ISebe leMicimbi yeZibhedlele ze-Oncology zaseBeijing South Region lizimisele ukuba liqabane lakho elithembekileyo ekulweni nezifo, linikezela ngobuchule bezonyango kunye neenkonzo ezifudumeleyo zamazwe ngamazwe.
**ISebe leHlabathi leSibhedlele se-Oncology saseBeijing South Region: Ngokuhamba neHlabathi, Ukukhusela Ubomi.**
Ixesha leposi: Jan-29-2026